KR101491867B1 - 증가된 발현을 위한 박테리아 리더 서열 - Google Patents

증가된 발현을 위한 박테리아 리더 서열 Download PDF

Info

Publication number
KR101491867B1
KR101491867B1 KR1020097017960A KR20097017960A KR101491867B1 KR 101491867 B1 KR101491867 B1 KR 101491867B1 KR 1020097017960 A KR1020097017960 A KR 1020097017960A KR 20097017960 A KR20097017960 A KR 20097017960A KR 101491867 B1 KR101491867 B1 KR 101491867B1
Authority
KR
South Korea
Prior art keywords
protein
polypeptide
delete delete
interest
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020097017960A
Other languages
English (en)
Korean (ko)
Other versions
KR20090114422A (ko
Inventor
러셀 존 콜맨
디안 레탈락
제인 씨. 쉬나이더
토마스 엠. 람세이어
찰스 더글라스 허쉬버거
스테이시 엘. 리
솔 레스닉
Original Assignee
피페넥스 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 피페넥스 인크. filed Critical 피페넥스 인크.
Publication of KR20090114422A publication Critical patent/KR20090114422A/ko
Application granted granted Critical
Publication of KR101491867B1 publication Critical patent/KR101491867B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • C12N15/625DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
KR1020097017960A 2007-01-31 2008-01-30 증가된 발현을 위한 박테리아 리더 서열 Active KR101491867B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US88747607P 2007-01-31 2007-01-31
US88748607P 2007-01-31 2007-01-31
US60/887,476 2007-01-31
US60/887,486 2007-01-31
PCT/US2008/052434 WO2008094986A2 (en) 2007-01-31 2008-01-30 Bacterial leader sequences for increased expression

Publications (2)

Publication Number Publication Date
KR20090114422A KR20090114422A (ko) 2009-11-03
KR101491867B1 true KR101491867B1 (ko) 2015-02-10

Family

ID=39462488

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097017960A Active KR101491867B1 (ko) 2007-01-31 2008-01-30 증가된 발현을 위한 박테리아 리더 서열

Country Status (10)

Country Link
US (3) US7618799B2 (enExample)
EP (2) EP2468869B1 (enExample)
JP (3) JP5714230B2 (enExample)
KR (1) KR101491867B1 (enExample)
CN (2) CN101641441A (enExample)
AU (1) AU2008210538B2 (enExample)
BR (1) BRPI0807834A2 (enExample)
CA (1) CA2677179C (enExample)
PL (1) PL2468869T3 (enExample)
WO (1) WO2008094986A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102527754B1 (ko) 2022-07-07 2023-04-28 배성규 필터정화기능을 구비한 초기우수처리장치

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
MXPA06005705A (es) * 2003-11-21 2006-08-23 Dow Global Technologies Inc Sistemas de expresion mejorada con secrecion de sistema de sec.
EP2412816B1 (en) 2004-07-26 2014-12-03 Pfenex Inc. Process for improved protein expression by strain engineering
US7618799B2 (en) * 2007-01-31 2009-11-17 Dow Global Technologies Inc Bacterial leader sequences for increased expression
CA2685326A1 (en) 2007-04-27 2008-11-06 Dow Global Technologies Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
AU2010236944B2 (en) 2009-04-17 2016-07-21 Dow Agrosciences Llc DIG-3 insecticidal Cry toxins
US7794969B1 (en) 2009-07-09 2010-09-14 Joule Unlimited, Inc. Methods and compositions for the recombinant biosynthesis of n-alkanes
PT2512222T (pt) 2009-12-16 2018-04-16 Dow Agrosciences Llc Utilização combinada das proteínas cry1ca e cry1fa para a gestão da resistência de insetos
WO2011109556A2 (en) * 2010-03-04 2011-09-09 Pfenex Inc. Method for producing soluble recombinant interferon protein without denaturing
AU2010201410B2 (en) * 2010-03-30 2015-04-30 Pelican Technology Holdings, Inc. High level expression of recombinant CRM197
US8530171B2 (en) * 2010-03-30 2013-09-10 Pfenex Inc. High level expression of recombinant toxin proteins
WO2011123570A2 (en) * 2010-04-01 2011-10-06 Pfenex Inc. Methods for g-csf production in a pseudomonas host cell
US9796983B2 (en) 2010-04-23 2017-10-24 Dow Agrosciences Llc Combinations including CRY3AA and CRY6AA proteins to prevent development of resistance in corn rootworms (Diabrotica spp.)
WO2012037285A2 (en) * 2010-09-14 2012-03-22 Joule Unlimited Technologies, Inc. Methods and compositions for targeting heterologous integral membrane proteins to the cyanobacterial plasma membrane
GB201106225D0 (en) * 2011-04-13 2011-05-25 Glaxosmithkline Biolog Sa Fermentation process
ES2864764T3 (es) 2011-05-11 2021-10-14 Childrens Medical Center Composición inmunogénica que presenta múltiples antígenos, y métodos y usos de la misma
US9109209B2 (en) 2011-09-08 2015-08-18 Codexis, Inc. Biocatalysts and methods for the synthesis of substituted lactams
EP2812018B1 (en) 2012-02-09 2018-12-05 University Of Rochester Novel sp-b&sp-c peptides, synthetic lung surfactants, and use thereof
CA2865033C (en) 2012-02-23 2021-11-02 Stage Cell Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
AR094276A1 (es) * 2012-12-21 2015-07-22 Alkem Laboratories Ltd Marcadores de fusion y sistema de vector de expresion para la expresion de hormona paratiroides humana (rhpth)
EP4272750A3 (en) 2013-02-07 2024-01-24 Children's Medical Center, Corp. Protein antigens that provide protection against pneumococcal colonization and/or disease
JP6436541B2 (ja) 2013-02-28 2018-12-12 コデクシス, インコーポレイテッド 工業的生体触媒作用のための操作されたトランスアミナーゼポリペプチド
ES2853935T3 (es) 2013-03-12 2021-09-20 Massachusetts Gen Hospital Proteínas modificadas de sustancia inhibidora muleriana (MIS) y usos de las mismas para el tratamiento de enfermedades
US9744223B2 (en) * 2013-03-15 2017-08-29 Panacea Pharmaceuticals, Inc. Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)
RU2013119826A (ru) 2013-04-29 2014-11-10 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") Коринеформная бактерия и способ получения гетерологичных гибридных белков
JP2017504589A (ja) 2013-12-11 2017-02-09 ザ ジェネラル ホスピタル コーポレイション 避妊および卵巣予備能の保存のためのミュラー管抑制物質(mis)タンパク質の使用
WO2015139046A1 (en) 2014-03-14 2015-09-17 Genentech, Inc. Methods and compositions for secretion of heterologous polypeptides
AR099800A1 (es) 2014-03-21 2016-08-17 Agrigenetics Inc Cry1d para controlar el gusano de la mazorca del maíz
KR101660580B1 (ko) * 2014-04-02 2016-09-28 프레스티지 바이오파마 피티이. 엘티디. 항체의 당 함량 조절을 통한 항체의 제조 방법
CN106455545B (zh) 2014-06-20 2021-03-09 美国陶氏益农公司 可用于控制昆虫有害生物的营养生长杀虫蛋白
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
KR102353262B1 (ko) 2014-12-01 2022-01-18 피페넥스 인크. 펩티드 생산용 융합 파트너
JP2018501798A (ja) 2014-12-30 2018-01-25 ダウ アグロサイエンシィズ エルエルシー 害虫の防除に有用な改変Cry1Ca毒素
AU2016253217B2 (en) * 2015-04-24 2021-09-02 Ajinomoto Co., Inc. Method for secretory production of protein
US10344078B2 (en) 2015-05-01 2019-07-09 Inhibrx, Inc. Type III secretion system targeting molecules
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
AU2016341527B2 (en) 2015-10-22 2023-04-27 Juno Therapeutics Gmbh Methods, kits, agents and apparatuses for transduction
WO2017167910A1 (en) * 2016-03-31 2017-10-05 Ethris Gmbh Novel minimal utr sequences
EP3522720A4 (en) 2016-09-30 2020-04-29 Dow Agrosciences LLC Binary insecticidal cry toxins
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
KR20190104342A (ko) * 2016-12-14 2019-09-09 바게닝겐 유니버시테이트 열안정성 cas9 뉴클레아제
EA035353B1 (ru) * 2017-02-28 2020-06-01 Акционерное Общество "Биоамид" Способ получения l-аспарагиновой кислоты и рекомбинантный штамм-продуцент аспартазы escherichia coli
US11305001B2 (en) 2017-03-28 2022-04-19 The Children's Medical Center Corporation Multiple antigen presenting system (MAPS)-based Staphylococcus aureus vaccine, immunogenic composition, and uses thereof
EP4647493A2 (en) 2017-04-27 2025-11-12 Juno Therapeutics, Inc. Oligomeric particle reagents and methods of use thereof
CN111065417B (zh) 2017-06-23 2024-04-19 美商艾芬尼维克斯公司 免疫原性组合物
WO2019083795A1 (en) 2017-10-27 2019-05-02 Pfenex Inc. GUIDED BACTERIAL SEQUENCES FOR EXPRESSION OF PERIPLASMIC PROTEINS
JP7358347B2 (ja) * 2017-10-27 2023-10-10 フェネックス インク. 組み換えE.coliアスパラギナーゼの製造のための方法
JP7784804B2 (ja) * 2017-10-27 2025-12-12 フェネックス インク. 組み換えerwiniaアスパラギナーゼの製造のための方法
CN111373033A (zh) * 2017-11-23 2020-07-03 豪夫迈·罗氏有限公司 脯氨酸羟化酶及其相关用途、方法和产品
KR101946789B1 (ko) * 2018-01-26 2019-02-12 (주)휴온스 이황화결합 이성질화효소 신호 펩타이드를 포함하는 재조합 벡터 및 이의 용도
CN110655560A (zh) * 2018-06-29 2020-01-07 复旦大学 T7噬菌体尾部纤维蛋白多肽及其应用
PE20211112A1 (es) 2018-09-12 2021-06-22 Affinivax Inc Vacunas neumococicas multivalentes
SG11202101973YA (en) 2018-09-12 2021-03-30 Childrens Medical Ct Corp Pneumococcal fusion protein vaccines
CN113453677A (zh) 2018-12-13 2021-09-28 沪亚生物国际有限责任公司 用于治疗急性心房颤动的舒卡定施用
US12152062B2 (en) * 2019-02-24 2024-11-26 Oncosimis Biotech Privated Limited Method for continuous production of recombinant GLP-1 peptide by bacteria
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
WO2022211829A1 (en) 2021-03-30 2022-10-06 Jazz Pharmaceuticals Ireland Ltd. Dosing of recombinant l-asparaginase
WO2023039223A1 (en) 2021-09-09 2023-03-16 Affinivax, Inc. Multivalent pneumococcal vaccines
CN120349035B (zh) * 2025-06-25 2025-11-11 上海明诺环境科技有限公司 一种聚甲醛废水处理方法及应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005089093A2 (en) * 2003-11-21 2005-09-29 Dow Global Technologies Inc. Improved expression systems with sec-system secretion

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4595658A (en) 1982-09-13 1986-06-17 The Rockefeller University Method for facilitating externalization of proteins synthesized in bacteria
US4511503A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4513600A (en) 1983-01-03 1985-04-30 The Minster Machine Company Cam actuated ejector for a shell press
GB8308483D0 (en) 1983-03-28 1983-05-05 Health Lab Service Board Secretion of gene products
US4755465A (en) 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US4680264A (en) 1983-07-01 1987-07-14 Lubrizol Genetics, Inc. Class II mobilizable gram-negative plasmid
US5281532A (en) 1983-07-27 1994-01-25 Mycogen Corporation Pseudomas hosts transformed with bacillus endotoxin genes
US4637980A (en) 1983-08-09 1987-01-20 Smithkline Beckman Corporation Externalization of products of bacteria
US5288852A (en) 1984-03-06 1994-02-22 Dainippon Pharmaceutical Co., Ltd. Human tumor necrosis factor polypeptides
EP0155189A3 (en) 1984-03-16 1987-09-16 Genentech, Inc. Expression of cell wall degrading proteins and host cells harboring dna encoding such protein
US4963495A (en) 1984-10-05 1990-10-16 Genentech, Inc. Secretion of heterologous proteins
ATE78515T1 (de) 1984-10-05 1992-08-15 Genentech Inc Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung.
US4695455A (en) 1985-01-22 1987-09-22 Mycogen Corporation Cellular encapsulation of pesticides produced by expression of heterologous genes
US4695462A (en) 1985-06-28 1987-09-22 Mycogen Corporation Cellular encapsulation of biological pesticides
GB8517071D0 (en) 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
GB8529014D0 (en) 1985-11-25 1986-01-02 Biogen Nv Enhanced secretion of heterologous proteins
US5232840A (en) 1986-03-27 1993-08-03 Monsanto Company Enhanced protein production in bacteria by employing a novel ribosome binding site
US5084384A (en) 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
EP0288451B1 (en) 1987-04-23 1994-08-10 Monsanto Company Secretion of insulin-like growth factor 1 in E. coli
US5128130A (en) 1988-01-22 1992-07-07 Mycogen Corporation Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
US5055294A (en) 1988-03-03 1991-10-08 Mycogen Corporation Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
AU3751689A (en) 1988-05-09 1989-11-29 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Vector for secretion of proteins directly into periplasm or culture medium
US5169772A (en) 1988-06-06 1992-12-08 Massachusetts Institute Of Technology Large scale method for purification of high purity heparinase from flavobacterium heparinum
US5175099A (en) 1989-05-17 1992-12-29 Research Corporation Technologies, Inc. Retrovirus-mediated secretion of recombinant products
US5169760A (en) 1989-07-27 1992-12-08 Mycogen Corporation Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
AU631719B2 (en) 1989-12-15 1992-12-03 W.R. Grace & Co.-Conn. Autodeposition emulsion for selectively protecting metallic surfaces
US5641671A (en) 1990-07-06 1997-06-24 Unilever Patent Holdings B.V. Production of active Pseudomonas glumae lipase in homologous or heterologous hosts
FI913434A7 (fi) 1990-07-16 1992-01-17 Technical Research Centre F Finland Rekombinanta fusionsproteiner vilka utsoendras.
CA2052852A1 (en) 1990-10-30 1992-05-01 Carl Rande Shervin Method of determining blend time in stirred tanks
JP3014434B2 (ja) 1990-10-31 2000-02-28 昭和アルミニウム株式会社 熱交換器
US5417971A (en) 1991-10-22 1995-05-23 University Of Saskatchewan Vaccines for Actinobacillus pleuropneumoniae
US5348867A (en) 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
DE69429858D1 (de) * 1993-04-09 2002-03-21 Bio Technology General Corp Herstellung eines rekombinanten inhibitors des faktors xa des blutegels hirudo medicinalis
US5563046A (en) * 1993-08-02 1996-10-08 Celtrix Pharmaceuticals, Inc. Fusion polypeptides and proteins
US5914254A (en) 1993-08-02 1999-06-22 Celtrix Pharmaceuticals, Inc. Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
US5527883A (en) 1994-05-06 1996-06-18 Mycogen Corporation Delta-endotoxin expression in pseudomonas fluorescens
ATE260979T1 (de) 1994-12-09 2004-03-15 Novo Nordisk As Verfahren zur herstellung extrazellulärer proteine in bakterien
US6495357B1 (en) 1995-07-14 2002-12-17 Novozyme A/S Lipolytic enzymes
IT1283225B1 (it) 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
US6361989B1 (en) 1997-10-13 2002-03-26 Novozymes A/S α-amylase and α-amylase variants
US6156552A (en) 1998-02-18 2000-12-05 Novo Nordisk A/S Lipase variants
US20030064435A1 (en) 1998-05-28 2003-04-03 Weiner Joel Hirsch Compositions and methods for protein secretion
US6323007B1 (en) 1998-09-18 2001-11-27 Novozymes A/S 2,6-β-D-fructan hydrolase enzyme and processes for using the enzyme
WO2000024873A1 (en) 1998-10-28 2000-05-04 Genentech, Inc. Process for recovering heterologous polypeptides from bacterial cells
KR100312456B1 (ko) 1999-03-13 2001-11-03 윤덕용 슈도모나스 플루오레슨스 유래의 외래단백질 분비촉진유전자
ATE450603T1 (de) 1999-03-29 2009-12-15 Novozymes As Polypeptide mit verzweigungsenzym-aktivität und für diese kodierende nukleinsäuren
US6664386B1 (en) 1999-04-08 2003-12-16 The Research Foundation Of State University Of New York System for efficient secretion of recombinant proteins
US6558939B1 (en) 1999-08-31 2003-05-06 Novozymes, A/S Proteases and variants thereof
DE19944870A1 (de) 1999-09-18 2001-03-29 Aventis Pharma Gmbh Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
FI107081B (fi) * 1999-10-19 2001-05-31 Abb Substation Automation Oy Menetelmä ja järjestely osittaispurkauslähteiden lukumäärän selvittämiseksi
US6617143B1 (en) 1999-10-20 2003-09-09 Novozymes A/S Polypeptides having glucanotransferase activity and nucleic acids encoding same
US6509181B1 (en) 2000-04-14 2003-01-21 Novozymes, A/S Polypeptides having haloperoxide activity
US7087412B2 (en) 2000-11-14 2006-08-08 Boehringer Ingelheim International Gmbh Methods for large scale protein production in prokaryotes
GB0027782D0 (en) 2000-11-14 2000-12-27 Boehringer Ingelheim Int Methods fro large scale protein productio in prokaryotes
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
DE10108212A1 (de) 2001-02-20 2002-08-22 Aventis Pharma Gmbh Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände
US7419783B2 (en) 2001-11-05 2008-09-02 Research Development Foundation Engineering of leader peptides for the secretion of recombinant proteins in bacteria
WO2003068948A1 (en) 2002-02-13 2003-08-21 Dow Global Technologies Inc. Over-expression of extremozyme genes in pseudomonads and closely related bacteria
WO2003079007A1 (en) 2002-03-15 2003-09-25 The Trustees Of The University Of Pennsylvania Heterologous protein production using the twin arginine translocation pathway
DE60329382D1 (de) 2002-04-22 2009-11-05 Dow Global Technologies Inc Kostengünstige herstellung von peptiden
ATE419265T1 (de) 2002-07-03 2009-01-15 Dow Global Technologies Inc Benzoat- und antranilatinduzierbare promotoren
PL1709170T3 (pl) 2004-01-16 2018-06-29 Pfenex Inc. Ekspresja białek ssaczych w Pseudomonas fluorescens
DK1902131T3 (da) * 2005-07-08 2010-03-01 Univ Zuerich Fag-display under anvendelse af cotranslational translokation af fusionspolypeptider
EP2021489A2 (en) * 2006-05-30 2009-02-11 Dow Global Technologies Inc. Codon optimization method
US7618799B2 (en) * 2007-01-31 2009-11-17 Dow Global Technologies Inc Bacterial leader sequences for increased expression
CA2685326A1 (en) * 2007-04-27 2008-11-06 Dow Global Technologies Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005089093A2 (en) * 2003-11-21 2005-09-29 Dow Global Technologies Inc. Improved expression systems with sec-system secretion

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANDREAS URBAN 등. J. BACTERIOL. Vol. 183, No. 2, 페이지 587-596 (2001) *
ANDREAS URBAN 등. J. BACTERIOL. Vol. 183, No. 2, 페이지 587-596 (2001)*

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102527754B1 (ko) 2022-07-07 2023-04-28 배성규 필터정화기능을 구비한 초기우수처리장치

Also Published As

Publication number Publication date
EP2108047A2 (en) 2009-10-14
AU2008210538B2 (en) 2013-06-06
CA2677179C (en) 2016-02-16
JP2015144608A (ja) 2015-08-13
CN101641441A (zh) 2010-02-03
US7618799B2 (en) 2009-11-17
KR20090114422A (ko) 2009-11-03
US7833752B2 (en) 2010-11-16
JP6495690B2 (ja) 2019-04-03
US20100048864A1 (en) 2010-02-25
JP2010517532A (ja) 2010-05-27
CA2677179A1 (en) 2008-08-07
EP2468869B1 (en) 2015-03-18
EP2468869A1 (en) 2012-06-27
BRPI0807834A2 (pt) 2014-07-22
EP2108047B1 (en) 2012-10-24
WO2008094986A8 (en) 2009-07-30
WO2008094986A2 (en) 2008-08-07
PL2468869T3 (pl) 2015-08-31
JP5714230B2 (ja) 2015-05-07
US20080193974A1 (en) 2008-08-14
WO2008094986A3 (en) 2008-11-20
US20110020868A1 (en) 2011-01-27
CN102517280A (zh) 2012-06-27
AU2008210538A1 (en) 2008-08-07
JP2018102305A (ja) 2018-07-05

Similar Documents

Publication Publication Date Title
KR101491867B1 (ko) 증가된 발현을 위한 박테리아 리더 서열
EP2327718B1 (en) Improved expression systems with SEC-system secretion
AU2008283991A1 (en) Translation initiation region sequences for the optimal expression of heterologous proteins
EP4596720A2 (en) Bacterial leader sequences for periplasmic protein expression
US8318481B2 (en) High copy number self-replicating plasmids in pseudomonas

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20090828

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20130130

Comment text: Request for Examination of Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20140307

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20140623

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20141219

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20150203

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20150203

End annual number: 3

Start annual number: 1

FPAY Annual fee payment

Payment date: 20150209

Year of fee payment: 4

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20180103

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20180103

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20190116

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20190116

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20210115

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20211215

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20240123

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20250121

Start annual number: 11

End annual number: 11